UBS AM’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8M | Buy |
|
|||||
|
2025
Q1 | $2.12M | Buy |
|
|||||
|
2024
Q4 | $1.9M | Buy |
|
|||||
|
2024
Q3 | $2.29M | Sell |
|
|||||
|
2024
Q2 | $2.23M | Buy |
|
|||||
|
2024
Q1 | $1.19M | Hold |
|
|||||
|
2023
Q4 | $946K | Hold |
|
|||||
|
2023
Q3 | $687K | Hold |
|
|||||
|
2023
Q2 | $737K | Hold |
|
|||||
|
2023
Q1 | $737K | Sell |
|
|||||
|
2022
Q4 | $850K | Buy |
|
|||||
|
2022
Q3 | $476K | Buy |
|
|||||
|
2022
Q2 | $499K | Sell |
|
|||||
|
2022
Q1 | $585K | Hold |
|
|||||
|
2021
Q4 | $536K | Hold |
|
|||||
|
2021
Q3 | $567K | Hold |
|
|||||
|
2021
Q2 | $679K | Buy |
|
|||||
|
2021
Q1 | $674K | Sell |
|
|||||
|
2020
Q4 | $610K | Buy |
|
|||||
|
2020
Q3 | $575K | Sell |
|
|||||
|
2020
Q2 | $491K | Sell |
|
|||||
|
2020
Q1 | $4.13M | Sell |
|
|||||
|
2019
Q4 | $6.01M | Sell |
|
|||||
|
2019
Q3 | $3.37M | Sell |
|
|||||
|
2019
Q2 | $3.91M | Sell |
|
|||||
|
2019
Q1 | $4.6M | Sell |
|
|||||
|
2018
Q4 | $5.24M | Buy |
|
|||||
|
2018
Q3 | $184K | Hold |
|
|||||
|
2018
Q2 | $298K | Buy |
|